合成肽疫苗在免疫抑制小鼠中诱导针对白色念珠菌感染的保护性免疫应答
本研究在免疫抑制小鼠侵袭性念珠菌病模型中,评估以合成肽3P-KLH(含白色念珠菌Als3、Hwp1和Met6蛋白表位)刺激的树突状细胞进行保护性免疫的策略。免疫有效刺激了体液和细胞免疫应答,表现为抗合成真菌肽抗体滴度高、细胞因子水平升高、肾脏真菌负荷降低和感染后生存改善。免疫小鼠肾组织真菌负荷较对照低64倍,62.5%免疫小鼠在感染后21天内存活,而对照组死亡率为100%。
要点
- 免疫刺激了体液和细胞免疫应答,抗合成真菌肽抗体滴度高、细胞因子水平升高。
- 免疫小鼠肾组织真菌负荷较对照低64倍,但对照组真菌负荷变异限制了真菌清除数据的统计学显著性。
- 62.5%免疫小鼠存活至感染后21天,对照组死亡率为100%。
核心结论
- 用合成肽3P-KLH免疫可刺激强烈的免疫应答,涉及抗体产生和细胞介导免疫,使其成为抗侵袭性念珠菌病治疗策略的有前景候选。
- 未来工作应聚焦于优化该免疫方法、评估长期免疫以及在其他真菌感染模型中评估其潜力。
研究设计与样本
- 研究在免疫抑制小鼠中建立侵袭性念珠菌病模型,评估以合成肽3P-KLH(含白色念珠菌Als3、Hwp1和Met6蛋白表位)刺激的树突状细胞进行保护性免疫的策略。
主要发现
- 免疫有效刺激了体液和细胞免疫应答,表现为抗合成真菌肽抗体滴度高、细胞因子水平升高、肾脏真菌负荷降低和感染后生存改善。
- 免疫小鼠肾组织真菌负荷较对照低64倍,但对照组真菌负荷的变异限制了真菌清除数据的统计学显著性。
- 细胞因子分析显示IL-2、IL-17和IFN-γ水平升高,提示Th1和Th17应答强烈激活。
- 62.5%免疫小鼠在感染后21天内存活,而对照组死亡率为100%。
- 存活小鼠真菌负荷随时间逐渐降低,提示持续免疫应答继续抑制真菌复制。
局限性
- 对照组真菌负荷的变异限制了真菌清除数据的统计学显著性。
- 未来工作应聚焦于优化该免疫方法、评估长期免疫以及在其他真菌感染模型中评估其潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Invasive fungal infections, such as those caused by Candida species, predominantly affects hospitalized and immunocompromised patients. Current mortality rates are expected to rise as drug-resistant fungal species increase and the pool of immunocompromised individuals grows. Today, antifungal treatments show limited effectiveness, underscoring the need for new safe and effective antifungal vaccines. This study investigates the efficacy of a protective immunization strategy with DC stimulated by a synthetic peptide, 3P-KLH, containing epitopes from three Candida albicans proteins (Als3, Hwp1 and Met6) against a model of invasive candidiasis raised in immunosuppressed mice. Immunization effectively stimulated both humoral and cellular immune responses, as indicated by high antibody titers to the synthetic fungal peptide, increased cytokine levels, reduced fungal burden in kidneys and improved survival outcomes following infection. Although the variability in fungal burden in the control group limited the statistical significance for fungal clearance data, immunized mice showed a 64-fold lower fungal burden in renal tissues compared to controls. Cytokine analysis revealed elevated levels of IL-2, IL-17, and IFN-γ, suggesting a strong activation of Th1 and Th17 responses, both essential for antifungal immunity. Survival data further supported the protective effect of the immunogenic agent: 62.5 % immunized mice survived the 21-day post-infection period compared to 100 % mortality in controls. The progressively lower fungal burden over time in surviving mice suggests a sustained immune response that continues to suppress fungal replication. These results suggest that the immunization with the synthetic peptide stimulates a strong immune response, involving both antibody production and cell-mediated immunity, making it a promising candidate for therapeutic strategies against invasive candidiasis. Future work should focus on optimizing this immunization approach, assessing long-term immunity, and evaluating its potential in other fungal infection models.
引用
- Diez A, Arrieta-Aguirre I, Carrano G, et al. A synthetic peptide vaccine induces protective immune responses against Candida albicans infection in immunocompromised mice. Vaccine. 2025. PMID: 40194489. doi:10.1016/j.vaccine.2025.127102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。